Kestra Medical Technologies Forecast, price target & analysts
Kestra Medical Technologies Target price 2026 - Analyst rating & recommendation
Kestra Medical Technologies Classifications & Recommendation
Kestra Medical Technologies Price Target
| Target Price | $30.60 |
| Price | $27.43 |
| Potential |
11.56%
register free of charge
|
| Number of Estimates | 9 |
|
9 Analysts have issued a price target Kestra Medical Technologies 2027 .
The average Kestra Medical Technologies target price is $30.60.
This is
11.56%
register free of charge
$33.60
22.49%
register free of charge
$28.28
3.10%
register free of charge
|
|
| A rating was issued by 14 analysts: 12 Analysts recommend Kestra Medical Technologies to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Kestra Medical Technologies stock has an average upside potential 2027 of
11.56%
register free of charge
|
Sales and Margin forecast 2027, 2028 & 2029
| Apr '26 |
2027 Estimates |
|
|---|---|---|
| Revenue Million $ | 95.13 | 139.76 |
| 59.03% | 46.91% | |
| EBITDA Margin | -132.48% | -61.96% |
| 19.47% | 53.23% | |
| Net Margin | -138.35% | -100.72% |
| 34.39% | 27.20% |
10 Analysts have issued a sales forecast Kestra Medical Technologies 2027 . The average Kestra Medical Technologies sales estimate is
This results in the following potential growth metrics:
9 Analysts have issued an Kestra Medical Technologies EBITDA forecast 2027. The average Kestra Medical Technologies EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
10 Kestra Medical Technologies Analysts have issued a net profit forecast 2027. The average Kestra Medical Technologies net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 & 2029
| Apr '26 |
2027 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -2.43 | -2.37 |
| 4.71% | 2.47% | |
| P/E | negative | |
| EV/Sales | 10.79 |
10 Analysts have issued a Kestra Medical Technologies forecast for earnings per share. The average Kestra Medical Technologies EPS is
This results in the following potential growth metrics and future valuations:
Kestra Medical Technologies...
Current Kestra Medical Technologies Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BTIG |
Locked
➜
Locked
|
Locked | Sep 15 2026 |
| BTIG |
Locked
➜
Locked
|
Locked | Sep 02 2026 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Aug 10 2026 |
| Oppenheimer |
Locked
➜
Locked
|
Locked | Jul 21 2026 |
| BTIG |
Locked
➜
Locked
|
Locked | Jul 15 2026 |
| Goldman Sachs |
Locked
➜
Locked
|
Locked | Apr 09 2026 |
| BTIG |
Locked
➜
Locked
|
Locked | Apr 07 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
BTIG:
Locked
➜
Locked
|
Sep 15 2026 |
|
Locked
BTIG:
Locked
➜
Locked
|
Sep 02 2026 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Aug 10 2026 |
|
Locked
Oppenheimer:
Locked
➜
Locked
|
Jul 21 2026 |
|
Locked
BTIG:
Locked
➜
Locked
|
Jul 15 2026 |
|
Locked
Goldman Sachs:
Locked
➜
Locked
|
Apr 09 2026 |
|
Locked
BTIG:
Locked
➜
Locked
|
Apr 07 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
